US Stock MarketDetailed Quotes

MIST Milestone Pharmaceuticals

Watchlist
  • 1.510
  • +0.057+3.92%
Close Jul 11 16:00 ET
  • 1.540
  • +0.030+1.99%
Post 18:44 ET
80.42MMarket Cap-1208P/E (TTM)

Milestone Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Milestone Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

-100.00%
EPS(YoY)

-0.21

+40.00%
Analyst Rating

Strong Buy

Jun 30, 2024

Milestone Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Milestone Pharmaceuticals Earnings Reports

  • Milestone Pharmaceuticals | 10-Q: Quarterly report

    May 13 07:03 ET

  • Milestone Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Apr 29 17:12 ET

  • Milestone Pharmaceuticals | 10-K: Annual report

    Mar 21 07:06 ET

  • Milestone Pharmaceuticals: Q3 2023 Earnings Report

    Nov 13, 2023 06:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg